• Skip to main content
Scientific Sessions
Scientific Sessions Conference Coverage logo
  • Program
  • #ScientificSessions26
Topics
  • Late-Breaking Science
  • Daily Coverage
  • Industry Highlights
  • Journeys
  • AHAtv
Resources
  • Program
  • #ScientificSessions26
User Tools
  • Privacy Policy
  • Terms & Conditions
  • Accessibility Statement
Twitter X icon Facebook iconInstagram iconYouTube iconPinterest iconLinkedIn icon
  • Late-Breaking Science
  • Daily Coverage
  • Industry Highlights
  • Journeys
  • AHAtv
Topics
  • Late-Breaking Science
  • Daily Coverage
  • Industry Highlights
  • Journeys
  • AHAtv
Resources
  • Program
  • #ScientificSessions26
User Tools
  • Privacy Policy
  • Terms & Conditions
  • Accessibility Statement
Twitter X icon Facebook iconInstagram iconYouTube iconPinterest iconLinkedIn icon
Science & Technology Hall
Visit the Science & Technology Hall
Connect with exhibitors. Learn something new.
Sep 11th, 2025
CME Dinner Symposium: Advancing Cardiovascular Care in FCS and sHTG
Sponsored by Ionis Pharmaceuticals
CME Dinner Symposium: Advancing Cardiovascular Care in FCS and sHTG
Breaking the Cycle : Addressing Residual Inflammatory Risk in ASCVD and CKD with Next-Generation Targeted Therapies
Sponsored by Catalyst
Breaking the Cycle : Addressing Residual Inflammatory Risk in ASCVD and CKD with Next-Generation Targeted Therapies
GE Cardio Solutions Learning Labs
Sponsored by American Heart Association
GE Cardio Solutions Learning Labs
Evidence-Based Strategies for the Treatment of Recurrent Pericarditis
Sponsored by Kiniksa Pharmaceuticals
Evidence-Based Strategies for the Treatment of Recurrent Pericarditis
Please join us for a complimentary CME-certified dinner symposium.
Sponsored by Edwards Lifesciences
Please join us for a complimentary CME-certified dinner symposium.
Clearing the Way from Echo to AVR: Addressing Obstacles to Timely Intervention in Severe Aortic Stenosis
Oct 24th, 2025
Exploring The Evidence: GLP-1 RAs in Individuals with T2D and ASCVD
Sponsored by NovoNordisk
Exploring The Evidence: GLP-1 RAs in Individuals with T2D and ASCVD
Reduce Your Patients’ CV Risk with GLP-1 RA Therapy: New Evidence
Oct 29th, 2025
Join us for an Expert Presentation
Sponsored by Ionis Pharmaceuticals
Join us for an Expert Presentation
Severe Hypertriglyceridemia (sHTG): An Underrecognized, Life-Threatening Condition
Dec 2nd, 2025
Meet June: A Conversation Between Patient and Cardiologist on Diagnosis, Dialogue, and Personal Impact of Obstructive Hypertrophic Cardiomyopathy
Sponsored by Cytokinetics
Meet June: A Conversation Between Patient and Cardiologist on Diagnosis, Dialogue, and Personal Impact of Obstructive Hypertrophic Cardiomyopathy
Join Cytokinetics for an Industry-Expert Presentation
Oct 23rd, 2025